Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

VARENICLINE

VARENICLINE

Standard Dose
0.5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview VARENICLINE is listed in Drugs@FDA under application 201920 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient VARENICLINE Form and strength TABLET; ORAL - 0.5MG Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2013-09-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview VARENICLINE is listed in Drugs@FDA under application 201920 (ANDA). Marketing status: None (Tentative Approval) Active ingredient VARENICLINE Form and strength TABLET; ORAL - 0.5MG Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2013-09-10 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.